Replies to post #410810 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

I said nothing of the sort. Please don't put words in my mouth.
I have no idea when or if Missling will publish full AD results. I gave up predicting what Missling will do some time ago.

Would I like to see the full AD data? Yes of course. Will me seeing that data change the outcome of the trial or its usefulness in obtaining an NDA? Not even a little bit.

The only value that me seeing that data has is if Missling is lying and actually missed the endpoints. Then I could bail on the stock. Well, there is that warm and fuzzy factor which might lead to a short term SP pop. Given the way AVXL has reacted to good news it would probably drop instead.

The company has repeatedly said it met endpoints. I accept that until shown otherwise.
Personally I'm in AVXL for approval, probably on multiple indications.

I don't think that WGT. I do think that the odds of success are strongly in Anavex's favor. Unknown unknowns can pop up at any time.

[boi568]

I think Missling would like to have some progress to report before an in-person annual meeting. I do think the PD Phase 3 trial initiation is likely before then, with a lesser but good chance of the AD 2b/3 follow up report.